ArticleJournal of orthopaedic surgery and research2026
Combined use of 18 F-FDG PET/CT and MRI for evaluating infection status and clinical outcomes before reimplantation in two-stage revision arthroplasty.
Article in Journal of orthopaedic surgery and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTwo stage revision arthroplasty (TSRA) is the standard treatment for periprosthetic joint infections (PJI); however, the utility of imaging in determining infection status before reimplantation remains unclear. The aim of this study was to evaluate whether pre-reimplantation 18 F-Fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) and magnetic resonance imaging (MRI) findings are associated with the risk of recurrent infection after second-stage revision arthroplasty.
methodsA total of 47 patients (26 women and 21 men) diagnosed with PJI according to the 2011 Musculoskeletal Infection Society (MSIS) criteria and treated with TSRA were retrospectively included in the study. A total of 26 hip and 21 knee PJI cases were evaluated. 18F-FDG PET/CT and MRI scans were obtained before reimplantation, and the images were interpreted by a radiologist and a nuclear medicine specialist blinded to the patient's clinical outcomes. 18F-FDG PET/CT and MRI findings were compared with postoperative infection outcomes.
resultsAfter reimplantation, no infection was observed in 33 patients, whereas 14 patients experienced infection recurrence requiring surgical intervention. 18F-FDG PET/CT alone identified 31 patients as infected and 16 as non-infected. 18F-FDG PET/CT results significantly correlated with clinical outcomes (p = 0.017). MRI alone identified 20 patients as infected and 27 as non-infected. A statistically significant association was observed between MRI findings and clinical outcomes (p = 0.009). When 18F-FDG PET/CT and MRI findings were combined, diagnostic accuracy improved, yielding a sensitivity of 100% and negative predictive value (NPV) of 100%.
conclusionA negative 18F-FDG PET/CT and MRI scan can provide an important reference point, strongly suggesting infection eradication and supporting a decision to proceed with the second stage of reimplantation surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.